Parathyroid resistance to FGF23 in kidney transplant recipients: Back to the past or ahead to the future

Kidney International

Volumn 78, Issue 10, 2010, Pages 953-955

  Komaba, Hirotaka ^a   Koizumi, Masahiro ^a   Fukagawa, Masafumi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR 1; KLOTHO PROTEIN; VITAMIN D RECEPTOR;

CELL CULTURE; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HUMAN; HYPERPARATHYROIDISM; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NODULAR HYPERPLASIA; NOTE; PARATHYROID CELL; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PATHOPHYSIOLOGY; PHOSPHATE EXCRETION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RENAL GRAFT DYSFUNCTION; SECONDARY HYPERPARATHYROIDISM; UREMIA; URINARY EXCRETION; VITAMIN D METABOLISM;

EID: 78049475648     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.283     Document Type: Note

References (16)

1. Shimada T, Hasegawa H, Yamazaki Y et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 2004; 19: 429-435.
2. Urakawa I, Yamazaki Y, Shimada T et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 2006; 444 : 770-774.
3. Kurosu H, Ogawa Y, Miyoshi M et al. Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem 2006; 281 : 6120-6123.
4. Komaba H, Fukagawa M. FGF23-parathyroid interaction: implications in chronic kidney disease. Kidney Int 2010; 77 : 292-298.
5. Shigematsu T, Yamashita T, Fukumoto S et al. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 2004; 44: 250-256.
6. Gutierrez O, Isakova T, Rhee E et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2205-2215.
7. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81 : 1598-1606.
8. Fukuda N, Tanaka H, Tominaga Y et al. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92 : 1436-1443.
9. Ben Dov IZ, Galitzer H, Lavi-Moshayoff V et al. T h e parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007; 117 : 4003-4008.
10. Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131.
11. Komaba H, Goto S, Fujii H et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 2010; 77 : 232-238.
12. Galitzer H, Ben-Dov IZ, Silver J et al. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 2010 ; 77: 211-218.
13. Canalejo R, Canalejo A, Martinez-Moreno JM et al. FGF23 Fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 2010; 7 : 1125-1135.
14. KrajisnikT, Olauson H, Mirza MAI et al. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients. Kidney Int 2010; 78 : 1024-1032.
15. Taniguchi M, Tokumoto M, Matsuo D et al. Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis. Kidney Int 2006; 70: 363-370.
16. Bhan I, Shah A, Holmes J et al. Post-transplant hypophosphatemia: Tertiary'Hyper-Phosphatoninism ' ? Kidney Int 2006; 70 : 1486-1494.